HOME >> BIOLOGY >> NEWS
Isoprene emission from plants -- a volatile answer to heat stress

Isoprene is a hydrocarbon volatile compound emitted in high quantities by many woody plant species, with significant impact on atmospheric chemistry. The Australian Blue Mountains and the Blue Ridge Mountains in the Eastern United States are so called because of the spectral properties of the huge amounts of isoprenes emitted from the trees growing there. Although a positive correlation has been observed between leaf temperature and isoprene emission in plants, the physiological role of isoprene emission, which is clearly quite costly to the plant, is still under vigorous debate.

One of the most popular hypotheses suggests that isoprene protects the metabolic processes in the leaf, in particular photosynthesis (the process by which plants use light energy to fix CO2 and produce their own food), against thermal stress. To test this hypothesis, scientists Katja Behnke and Jrg-Peter Schnitzler from the Institute for Meteorology and Climate Research of the Research Centre Karlsruhe in Garmisch-Partenkirchen in Germany, together with colleagues from the Universities of Braunschweig and Gttingen, also in Germany, and British Columbia, in Canada, recently applied genetic engineering techniques to obtain transgenic Grey poplar (Populus x canescens) trees with decreased isoprene emission, and examined their tolerance to heat. Their findings have been published in The Plant Journal.

Behnke et al. engineered such poplar trees by suppressing the expression of the gene encoding isoprene synthase (ISPS), the enzyme producing isoprene, by RNA interference (RNAi). They then subjected these trees to transient heat phases of 38-42C, each followed by phases of recovery at 30C, and measured the performance of photosynthesis. In these experiments, Behnke et al. observed that photosynthesis in trees that no longer emitted isoprenes was much less efficient under such repeated heat shocks (a situation that is similar to what happens in nature, where temperatures around
'"/>

Contact: Davina Quarterman
davina.quarterman@oxon.blackwellpublishing.com
01-865-476-307
Blackwell Publishing Ltd.
26-Jul-2007


Page: 1 2

Related biology news :

1. Climate change and permafrost thaw alter greenhouse gas emissions in northern wetlands
2. Particle emissions from laser printers might pose health concern
3. New multiple myeloma treatment induced total remission in 33 percent of patients
4. Blood test may help signal tumors remission, return in throat cancer patients
5. Alarming acceleration in CO2 emissions worldwide
6. Carnegie Mellon researchers urge regulators to rethink strategies for soot emission
7. Fires fuel mercury emissions, University of Michigan study finds
8. Global warming of the future is projected by ancient carbon emissions
9. Increase in carbon dioxide emissions accelerating
10. UGA scientists discover bacterial switch gene that regulates oceans sulfur emissions into the air
11. Study considers auto industry and consumer behavior in reducing greenhouse gas emissions

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Isoprene emission from plants volatile answer heat stress

(Date:5/5/2015)... 5, 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, reminds investors and media that ... is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series ... is themed Global Fraud: Where is the Trust in ...
(Date:4/27/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces that its Wocket® Smart ... week of May, 2015 and will be fulfilling all ... Gino Pereira , Chief Executive Officer said, ... Wocket® enters the consumer market. We would like to ...
(Date:4/21/2015)... 2015 High crime rate, ... boosting access control systems market in Saudi ... recently published report by TechSci Research " Saudi Arabia Access ... control systems market in Saudi Arabia ... access control systems market in the Kingdom is growing ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3
(Date:5/21/2015)... , May 21, 2015  Prima Biomed Ltd. ... that is striving to become a leader in the ... recently announced that the final CVac data from the ... a clear trend for a clinically meaningful improvement in ... second remission patients. In the group of ...
(Date:5/21/2015)... 21, 2015 Imagine being able ... and those of others. Being able to read faces ... read people to anticipate their thoughts and actions like ... and feelings to create unique abstract paintings and video, ... Get inside a first-person-shooter as it creates action, dialog, ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: RP) ... focused on the development of autologous cell therapies, ... International Society for Cellular Therapy (ISCT) on RepliCel,s ... in a Phase 1/2 clinical trial.  The presentation, ... 5:30 PM to 7:00 PM local time, will ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 25 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3
Cached News: